Condition: Brain Metastases, Adult · Sponsor: Susanne Rogers
The research question is whether a single fraction of preoperative radiosurgery can reduce the incidence of leptomeningeal disease 12 months following resection of a brain metastasis (BM) as compared with 5 fractions of postoperative stereotactic radiotherapy.
This description comes directly from the study's public registry record.
Susanne Rogers, MD PhD · +41 62 838 57 26 · Susanne.rogers@ksa.ch
Oliver Riesterer, Prof. · +41 62 838 4249 · oliver.riesterer@ksa.ch
Always discuss trial participation with your own doctor first.
| Tirol Kliniken Innsbruck | Innsbruck, Austria | Active Not Recruiting |
| Knappschaft Kliniken, Universitätsklinikum Bochum GmbH | Bochum, Germany | Recruiting |
| UKGM-Giessen | Giessen, Germany | Recruiting |
| Universitätsklinikum Schleswig Holstein | Kiel, Germany | Recruiting |
| Kantonsspital Aarau | Aarau, Canton of Aargau, Switzerland | Recruiting |
| Inselspital, Universitätsklinik für Radio-Onkologie | Bern, Freiburgstrasse, Switzerland | Recruiting |
| Kantonsspital Graubünden | Chur, Switzerland | Recruiting |
| Luzerner Kantonsspital | Lucerne, Switzerland | Recruiting |
| Kantonsspital St. Gallen | Sankt Gallen, Switzerland | Recruiting |
| Kantonsspital Winterthur | Winterthur, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05124236